Genes LP32747-5

LOINC Hierarchy

LOINC part code	LP32747-5
name	Genes
type	COMPONENT
status	ACTIVE
children	LOINC Home {component} LP432695-7 Laboratory LP29693-6 Molecular pathology LP7822-2 Genes LP32747-5 ▸ Abnormal clonal sequences LP437683-8 ▸ Genetic disease DNA and RNA analysis LP436408-1 ▸ Hereditary Wilms tumor multigene analysis LP435136-9 ▸ Erythrocytosis multigene analysis LP437807-3 ▸ Erythrocytosis focused multigene analysis LP437808-1 ▸ EBV Lymphoproliferation multigene analysis LP437811-5 ▸ Dysregulation autoimmune multigene analysis LP437823-0 ▸ Dyserythropoietic anemia multigene analysis LP437806-5 ▸ Distal weakness multigene analysis LP437803-2 ▸ Hereditary spastic paraplegia multigene analysis LP437802-4 ▸ Hereditary sensory neuropathy multigene analysis LP437801-6 ▸ Hereditary Motor Neuropathy multigene analysis LP437337-1 ▸ Hereditary motor and sensory neuropathy multigene analysis LP437800-8 ▸ Hereditary emery dreifuss multigene analysis LP437805-7 ▸ Hereditary congenital myasthenic syndrome multigene analysis LP437804-0 ▸ HMEP-Hemiplegic migraine multigene analysis LP437792-7 ▸ Hyper igE syndrome multigene analysis LP437822-2 ▸ Histiocytic neoplasm multigene analysis LP437332-2 ▸ Plasma cell myeloma multigene analysis LP437879-2 ▸ T cell lymphoma multigene analysis LP437880-0 ▸ RBC membrane multigene analysis LP437810-7 ▸ DNA fragmentation index LP441136-1 ▸ Cystinuria multigene analysis LP442254-1 ▸ SDHA and SDHB and SDHC and SDHD targeted gene mutation analysis LP441834-1 ▸ Renal cell carcinoma multigene analysis LP441802-8 ▸ Renal cell carcinoma fibromyomatous stroma multigene analysis LP441800-2 ▸ POLE targeted gene mutation analysis LP441833-3 ▸ Ovarian, fallopian tube and peritoneal carcinoma multigene analysis LP441804-4 ▸ NTRK1 and NTRK2 and NTRK3 targeted gene mutation analysis LP441830-9 ▸ MYOD1 targeted gene mutation analysis LP441799-6 ▸ Multiple myeloma minimal residual disease analysis LP437816-4 ▸ Mutations LP7824-8 ▸ Nucleotide repeats LP193279-9 ▸ MYC and BCL2 rearrangements LP434773-0 ▸ Myeloid sarcoma analysis LP435023-9 ▸ T-Cell acute lymphoblastic leukemia LP434699-7 ▸ Viral Susceptibility multigene analysis LP437825-5 ▸ Autoimmune lymphoproliferative syndrome multigene analysis LP437826-3 ▸ Breast Cancer recurrence risk multigene analysis LP437602-8 ▸ B cell non hodgkin Lymphoma multigene analysis LP437882-6 ▸ Chronic and low grade B cell lymphoid neoplasm multigene analysis LP437881-8

Copyright © 2026 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2026, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.

Thank you for choosing Find-A-Code, please Sign In to remove ads.

MY NEWSLETTERS

FEES

FACILITY

RISK ADJUSTMENT

LOINC Home

{component} LP432695-7

Laboratory LP29693-6

Molecular pathology LP7822-2

Genes LP32747-5

LOINC Hierarchy

▸ Abnormal clonal sequences LP437683-8

▸ Genetic disease DNA and RNA analysis LP436408-1

▸ Hereditary Wilms tumor multigene analysis LP435136-9

▸ Erythrocytosis multigene analysis LP437807-3

▸ Erythrocytosis focused multigene analysis LP437808-1

▸ EBV Lymphoproliferation multigene analysis LP437811-5

▸ Dysregulation autoimmune multigene analysis LP437823-0

▸ Dyserythropoietic anemia multigene analysis LP437806-5

▸ Distal weakness multigene analysis LP437803-2

▸ Hereditary spastic paraplegia multigene analysis LP437802-4

▸ Hereditary sensory neuropathy multigene analysis LP437801-6

▸ Hereditary Motor Neuropathy multigene analysis LP437337-1

▸ Hereditary motor and sensory neuropathy multigene analysis LP437800-8

▸ Hereditary emery dreifuss multigene analysis LP437805-7

▸ Hereditary congenital myasthenic syndrome multigene analysis LP437804-0

▸ HMEP-Hemiplegic migraine multigene analysis LP437792-7

▸ Hyper igE syndrome multigene analysis LP437822-2

▸ Histiocytic neoplasm multigene analysis LP437332-2

▸ Plasma cell myeloma multigene analysis LP437879-2

▸ T cell lymphoma multigene analysis LP437880-0

▸ RBC membrane multigene analysis LP437810-7

▸ DNA fragmentation index LP441136-1

▸ Cystinuria multigene analysis LP442254-1

▸ SDHA and SDHB and SDHC and SDHD targeted gene mutation analysis LP441834-1

▸ Renal cell carcinoma multigene analysis LP441802-8

▸ Renal cell carcinoma fibromyomatous stroma multigene analysis LP441800-2

▸ POLE targeted gene mutation analysis LP441833-3

▸ Ovarian, fallopian tube and peritoneal carcinoma multigene analysis LP441804-4

▸ NTRK1 and NTRK2 and NTRK3 targeted gene mutation analysis LP441830-9

▸ MYOD1 targeted gene mutation analysis LP441799-6

▸ Multiple myeloma minimal residual disease analysis LP437816-4

▸ Mutations LP7824-8

▸ Nucleotide repeats LP193279-9

▸ MYC and BCL2 rearrangements LP434773-0

▸ Myeloid sarcoma analysis LP435023-9

▸ T-Cell acute lymphoblastic leukemia LP434699-7

▸ Viral Susceptibility multigene analysis LP437825-5

▸ Autoimmune lymphoproliferative syndrome multigene analysis LP437826-3

▸ Breast Cancer recurrence risk multigene analysis LP437602-8

▸ B cell non hodgkin Lymphoma multigene analysis LP437882-6

▸ Chronic and low grade B cell lymphoid neoplasm multigene analysis LP437881-8